Is There A Doctor On Board?!?
I’ll teach you how to become the media’s go-to expert in your field. Enroll in The Professional’s Media Academy now: https://www.professionalsmediaacademy.co…
Related Articles
Haematological setpoints are a stable and patient-specific deep phenotype
Nature – Complete blood count indices are tightly regulated around setpoints for decades in healthy adults, and represent a deep phenotype providing opportunities for investigating…
Syria: Stories from people freed from Saydnaya torture prison
The BBC speaks to men released from Saydnaya prison – a place known as the “human slaughterhouse”.
Myeloma Paper of the Day, December 14th, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, December 14th, suggested by Robert Orlowski / Andri Olafsson, Ásbjörn Jónsson, Bjarni Agnarsson, Brynjar Viðarsson, cancer, Edith
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
PURPOSESWOG S1815 was a randomized, open label phase III trial, evaluating gemcitabine, nab-paclitaxel, and cisplatin (GAP) versus gemcitabine and cisplatin (GC) in patients with newly…
Finding Hope With Antibody-Drug Conjugates in Managing Breast Cancer
With more than 150 treatments being studied in clinical trials, what is on the horizon for antibody-drug conjugates in breast cancer?
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
PURPOSESWOG S1815 was a randomized, open label phase III trial, evaluating gemcitabine, nab-paclitaxel, and cisplatin (GAP) versus gemcitabine and cisplatin (GC) in patients with newly…
PULMONARY EMBOLISM | Dr Chadi Alraies
A pulmonary embolism is when a blood clot blocks a blood vessel in your lungs. It can be life-threatening if not treated quickly.In this episode…
Cause of Vision Loss & Treating Vision Loss | Dr. Jeff Goldberg & Dr. Andrew Huberman
Dr. Jeffrey Goldberg and Dr. Andrew Huberman discuss the impact of diabetes on the eyes and the importance of early screening and treatment for diabetic…
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial
Previously, addition of isatuximab (Isa) to standard-of-care lenalidomide-bortezomib-dexamethasone (RVd) in transplant-eligible patients with newly diagnosed multiple myeloma in the GMMG-HD7 trial (ClinicalTrials.gov identifier: NCT03617731) resulted…
An open letter to Harvard President, Alan Garber
Reinstate Martin Kulsdorf and others fired because of Biden’s COVID-19 vaccine mandate
